A randomized controlled trial to evaluate outcomes with Aggrenox in patients with SARS-CoV-2 infection. Singla A, Dadario NB, Singla A, Greenberg P, et al. PLoS One 2023;18:e0274243.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Singla A, Dadario NB, Singla A, Greenberg P, et al. A randomized controlled trial to evaluate outcomes with Aggrenox in patients with SARS-CoV-2 infection. PLoS One 2023;18:e0274243.
PMID: 36716303